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While small organic molecules generally crystallize forming
tightly packed lattices with little solvent content, proteins form
air-sensitive high-solvent-content crystals. Here, the crystal-
lization and full structure analysis of a novel recombinant
10 kDa protein corresponding to the C-terminal domain of
a putative U32 peptidase are reported. The orthorhombic
crystal contained only 24.5% solvent and is therefore among
the most tightly packed protein lattices ever reported.
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1. Introduction
Unlike inorganic and organic crystals, protein crystals are very
fragile (McPherson, 1999). This is a result of far fewer and
much weaker interactions contributing to the crystalline
architecture in proportion to the molecular mass of the
molecule composing the crystal (Drenth & Haas, 1992). This
also affects the kinetic parameters of crystal growth: whereas
small-molecule crystals crystallize within minutes or a few
days, proteins generally require a much longer time, some-
times weeks or months. The majority of these properties result
from a single feature: the solvent content (McPherson, 1999).
While metal and atomic crystals are completely anhydrous,
inorganic ionic crystals may be anhydrous, like rock salt, or
may contain a few water molecules per molecular unit. The
same holds for organic small-molecule crystals, for which the
solvent content is generally between 23 and 35% (Kitaigor-
odskii, 1973). In contrast, protein crystals have a high solvent
content per volume. For most protein crystals, this varies from
40 to 60%; very few protein crystals have been reported with
solvent contents of <30% or >90% (McPherson, 1999;
Matthews, 1968). In addition, solvent molecules are generally
ordered in all parts of organic and inorganic crystals; in
contrast, macromolecular crystals have large channels of only
partially ordered solvent. As a result, protein crystals cannot
be dehydrated and prolonged exposure to air results
in destruction of the crystalline order (Bernal & Crowfoot,
1934).
Here, we report the crystal structure determination and
crystal-packing analysis of a 10 kDa protein, the C-terminal
domain of the putative U32 peptidase from Geobacillus
thermoleovorans, and analyze the ﬁndings in the general
context of the Protein Data Bank.
2. Materials and methods
2.1. Protein production and purification
A gene coding for a hypothetical U32-type peptidase from
G. thermoleovorans (previously G. lituanicus; Dinsdale et al.,
2011; 422 residues; 47 928 Da; UniProt code G5DCB7; L2V
mutation for cloning strategy) was cloned into a modiﬁed
pET-28a vector using NcoI and SalI restriction sites and was
veriﬁed by DNA sequencing. The protein was produced by
heterologous overexpression in Escherichia coli BL21 (DE3)
cells, which were grown at 310 K in Luria–Bertani medium
supplemented with kanamycin to a ﬁnal concentration of
30 mg ml1. Cell cultures were induced at an OD550 of 0.8 with
isopropyl -d-1-thiogalactopyranoside to a ﬁnal concentration
of 1 mM and growth was continued for 5 h at 310 K. The
selenomethionine variant was obtained in the same way
except that the cells were grown in minimal medium
containing selenomethionine (Sigma) instead of methionine.
After centrifugation at 7000g for 30 min at 277 K, the pellet
was washed twice with buffer A (50 mM Tris–HCl, 250 mM
NaCl, 20 mM -mercaptoethanol pH 8.0) and resuspended
in the same buffer containing EDTA-free protease-inhibitor
cocktail tablets (Roche Diagnostics) and DNase I (Roche
Diagnostics). The cells were lysed at 277 K using a cell
disrupter (Constant Systems) at a pressure of 135 MPa, the
cell debris was removed by centrifugation at 50 000g for 1 h at
277 K and the supernatant was ﬁltered (0.22 mm pore size;
Millipore). The protein was found to serendipitously bind
nickel–nitrilotriacetic acid (Ni–NTA) resin despite the
absence of a polyhistidine tag. As such, the sample was incu-
bated with Ni–NTA resin (Invitrogen) previously equilibrated
with buffer A and eluted using the same buffer plus 150 mM
imidazole. The protein was subsequently puriﬁed by size-
exclusion chromatography on a HiLoad 26/60 Superdex 75
column previously equilibrated with buffer B [20 mM Tris–
HCl, 150 mM NaCl, 1 mM tris(2-carboxyethyl)phosphine
(TCEP), pH 8.0]. The protein identity and purity were
assessed by Edman degradation, peptide mass ﬁngerprinting
and 15% Tricine–SDS–PAGE stained with Coomassie Blue.
Fractions containing the 48 kDa protein were pooled,
concentrated to 30 mg ml1 by ultraﬁltration using Vivaspin
15 ﬁlter devices with a 10 kDa cutoff (Sartorius Stedim
Biotech) and incubated for 48 h at 310 K to test the stability of
the protein over time. After incubation, the sample showed
strong precipitation and was therefore centrifuged at 16 000g
for 10 min at 277 K; the supernatant was subsequently ﬁltered.
SDS–PAGE analysis of this supernatant showed the presence
of a major band at 10.4 kDa, which we attribute to repro-
ducible heterologous cleavage by a contaminating peptidase.
This protein species was puriﬁed by size-exclusion chroma-
tography on a HiLoad 16/60 Superdex 75 column previously
equilibrated with buffer C (20 mM Tris–HCl, 50 mM NaCl,
1 mM TCEP pH 7.5) and eluted as a monomer. Edman-
degradation and mass-spectrometric analyses (10 392 Da;
experimental molecular mass with internal calibration)
revealed that this species corresponded to the C-terminal
region of the U32-type peptidase spanning the segment
Ser334–Asn422 (hereafter referred to as GT-U32-CTD; 89
residues; calculated molecular mass 10 395 Da). The protein
was further concentrated to 75 mg ml1 using Vivaspin 15 and
500 ﬁlter devices with a 5 kDa cutoff. The protein concen-
tration was determined by measuring the absorbance at
280 nm using a spectrophotometer (NanoDrop) and a calcu-
lated absorption coefﬁcient "0.1% of 0.82.
2.2. Crystallization and X-ray diffraction data collection
Crystallization assays for GT-U32-CTD were carried out by
the sitting-drop vapour-diffusion method using 96  2-well
MRC plates (Innovadyne) and a Cartesian nanodrop robot
(Genomic Solutions) at the IBMB/IRB crystallization service.
Crystallization plates were stored in Bruker steady-tempera-
ture crystal farms at 277 and 293 K. Successful hits were scaled
up to the microlitre range in 24-well Cryschem crystallization
plates (Hampton Research). The best crystals of native
GT-U32-CTD appeared at 293 K using protein solution at
75 mg ml1 in buffer C containing 1 mM phenylmethyl-
sulfonyl ﬂuoride and reservoir solution consisting of 100 mM
sodium acetate, 200 mM ammonium acetate, 30%(w/v) poly-
ethylene glycol 4000 pH 4.6 in microlitre plates. The best
crystals of the selenomethionine-derivatized protein were
obtained from microlitre drops at 293 K using protein solution
at 75 mg ml1 in buffer C and reservoir solution consisting
of 100 mM sodium citrate, 2M ammonium sulfate pH 5.5.
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Table 1
Crystallographic data.
Values in parentheses are for the outermost resolution shell.
Data set Native
Selenomethionine
(absorption peak)†
Space group P212121 P3221
Unit-cell parameters (A˚) a = 28.40,
b = 36.30,
c = 65.67
a = b = 45.55,
c = 60.90
Wavelength (A˚) 0.9724 0.9791
No. of measurements 200643 131989
No. of unique reﬂections 27941 26349
Resolution range (A˚) 32.8–1.10
(1.16–1.10)
39.5–1.15
(1.21–1.15)
Completeness (%) 98.8 (96.0) 99.7 (98.8)
Anomalous completeness (%) 97.2 (91.0)
Rmerge‡ 0.116 (0.159) 0.036 (0.348)
Rr.i.m. (= Rmeas)‡ 0.125 (0.172) 0.045 (0.459)
Rp.i.m.‡ 0.046 (0.066) 0.026 (0.296)
Average intensity {h[hIi/(hIi)]i} 13.7 (8.6) 19.0 (3.3)
B factor (Wilson) (A˚2) 6.6 11.4
Average multiplicity 7.2 (6.3) 5.0 (3.7)
Resolution range used for reﬁnement (A˚) 1–1.10 1–1.15
No. of reﬂections used 27158 25557
No. of reﬂections used for test set 734 792
Crystallographic R factor‡ 0.123 0.141
Free R factor‡ 0.163 0.170
No. of protein atoms 760 692
No. of solvent molecules 108 80
No. of ligands 1 acetate,
1 cation
1 sulfate
R.m.s.d. from target values, bonds (A˚) 0.015 0.014
R.m.s.d. from target values, angles () 2.33 2.44
Average B factor for protein atoms (A˚2) 10.4 18.3
Main-chain conformational angle analysis§
Residues in favoured regions 85 78
Outliers 0 0
All residues 87 80
† Friedel mates were treated as separate reﬂections. ‡ For deﬁnitions, see Table 1 in
Mallorquı´-Ferna´ndez et al. (2008). § According to MolProbity (Chen et al., 2010).
Crystals were cryoprotected by successive passages through
reservoir solution containing increasing amounts of glycerol
[up to 20–25%(v/v)]. Complete diffraction data sets were
collected at 100 K from liquid-nitrogen ﬂash-cryocooled
crystals (Oxford Cryosystems 700 series cryostream) using a
PILATUS 6M pixel detector (Dectris) on beamline ID29
of the European Synchrotron Radiation Facility (ESRF)
Grenoble, France within the Block Allocation Group ‘BAG
Barcelona’ (native protein) and using an ADSC Q315R CCD
detector on beamline PROXIMA 1 of synchrotron SOLEIL,
Paris, France (selenomethionine-derivatized protein). The
crystals of native and selenomethionine-derivatized protein
were orthorhombic (maximal resolution 1.10 A˚) and trigonal
(maximal resolution 1.15 A˚), respectively, with one molecule
per asymmetric unit. Mass-spectrometric analysis of carefully
washed crystals revealed the presence of full-length GT-U32-
CTD (approximately 60%) and three shorter forms that
lacked two, three and ﬁve N-terminal residues, respectively
(approximately 40% in total). Diffraction data were inte-
grated, scaled, merged and reduced using the programs XDS
(Kabsch, 2010) and SCALA (Evans, 2006) within the CCP4
suite (Winn et al., 2011; Table 1).
2.3. Structure determination and refinement
The structure was determined by single-wavelength anom-
alous diffraction using the selenomethionine derivative and
the program SHELXD (Sheldrick, 2010). Diffraction data
were collected from a crystal at the selenium absorption-peak
wavelength, as inferred from a previous XANES ﬂuorescence
scan, and enabled the program to identify the two selenium
sites of the monomer present in the asymmetric unit. Subse-
quent phasing with SHELXE (Sheldrick, 2010), including
implementation of the ‘free-lunch’ algorithm and auto-tracing,
resolved the twofold ambiguity intrinsic to a SAD experiment
owing to the difference in the values of the pseudo-free
correlation coefﬁcients of the two possible hands (79.2%
versus 49.8%), which conﬁrmed P3221 as the correct space
group. An initial model was built into the experimental elec-
tron density with the program TURBO-FRODO (Carranza et
al., 1999) on a Silicon Graphics Octane2 workstation and was
reﬁned with PHENIX (Adams et al., 2002), BUSTER (Blanc
et al., 2004) and SHELXL (Sheldrick, 2008). This model was
employed to solve the native structure (true space group
P212121) by molecular replacement (Huber, 1965) using
Phaser (McCoy, 2007), which rendered one unambiguous
solution with Z-scores of 9.7 and 13.8 for the rotation and
translation functions, respectively. Model building and
reﬁnement, which included TLS reﬁnement and reﬁnement
of anisotropic thermal displacement parameters, proceeded as
described above. The ﬁnal native model comprised all of the
residues of the protein (Ser334–Asn422) plus one oxygen-
pentacoordinated cation, an acetate ion and 108 solvent
molecules. Table 1 provides a summary of data collection and
ﬁnal model reﬁnement.
2.4. Solvent-content analysis
A solvent-content distribution for all X-ray crystal struc-
tures deposited in the Protein Data Bank (PDB) before
September 2012 was calculated for a nonredundant set of
unique crystal forms. To obtain this data set, structures that
share equivalent asymmetric units were clustered together.
The crystal structures in each cluster possessed the same
polypeptide composition, were determined in the same space
group and showed differences of up to 5% in unit-cell volume.
The working pipeline was composed of the following steps.
Firstly, to determine the polypeptide composition, each protein
structure was labelled with a formula describing the number of
polypeptides and their sequence-cluster identiﬁers. The pre-
calculated sequence clusters had been generated by BLAST
(Altschul et al., 1990) using a 90% identity threshold (obtained
from ftp://resources.rcsb.org/sequence/clusters/). At this stage,
the data set contained clusters of all possible protein assem-
blies. Sequences shorter than 20 amino acids, split entries,
virus capsids, synthetic constructs, complexes with nucleic
acids, polysaccharides and d-polypeptides were excluded from
the analysis. Structures missing 20% or more of the residues of
the associated sequence were likewise rejected. Next, the
aforementioned clusters were subdivided based on the crystal
space group and unit-cell volume. The latter were calculated
based on the unit-cell dimensions deﬁned in the mmCIF ﬁles
using theMATTHEWS_COEF program from the CCP4 suite
(Matthews, 1968; Kantardjieff & Rupp, 2003). The molecular
weight of the polypeptides in the asymmetric unit was calcu-
lated from the sequences reported by the authors using the
ProtParam methodology (Gasteiger et al., 2005). Repre-
sentatives of each ﬁnal cluster were chosen based on a simple
quality factor deﬁned as 1/resolution  R value. For the
resulting data set, the solvent content of each protein crystal
structure was determined using MATTHEWS_COEF
(Kantardjieff & Rupp, 2003; Matthews, 1968). Subsequently,
manual curation of the ﬁnal data set enabled the removal
of special cases in which the structures were the result of
ensemble reﬁnement (PDB entries 1cwq and 1gtv), desiccated
crystals and those obtained by phase transition (PDB entries
1c0c, 1xek, 1xej and 1v7t), crystals with ‘order–disorder’
(Pletnev et al., 2009; PDB entry 3h1r) and other nonstandard
protocols for structure determination (PDB entries 3gi0 and
2xge). Cases for which the solvent content was artiﬁcially low
owing to long missing N- and C-terminal fragments were not
considered either (PDB entries 2xnq, 2duy, 2axo, 3bqh, 2f9l,
3m4s, 3nzl, 2xjx, 4eti, 2ds8 and 1vfq). The ﬁnal resulting data
set consisted of 35 656 X-ray structures.
2.5. Miscellaneous
Figures were prepared with TURBO-FRODO and UCSF
Chimera (Pettersen et al., 2004). The total interaction surface
(taken as half of the surface area buried at a complex inter-
face; probe radius 1.4 A˚) and close contacts (deﬁned as atoms
separated by less than 4 A˚) were determined using CNS
(Bru¨nger et al., 1998). Pairwise interaction surfaces were
calculated with the PISA server (http://www.ebi.ac.uk/msd-srv/
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prot_int/pistart.html; Krissinel & Henrick, 2005). Surface
shape complementarity was calculated with the program SC
(Lawrence & Colman, 1993) within CCP4 with a probe radius
of 1.4 A˚. Structure similarities were investigated with DALI
(Holm & Rosenstro¨m, 2010). Model validation was performed
with MolProbity (Chen et al., 2010) and the WHAT_CHECK
routine of WHAT IF (Vriend, 1990). The ﬁnal coordinates
of native and selenomethione-derivatized GT-U32-CTD have
been deposited in the PDB (http://www.pdb.org; accession
codes 4he5 and 4he6).
3. Results and discussion
3.1. Crystallization and structure determination
We studied the crystal structure of the C-terminal domain
of a putative peptidase from G. thermoleovorans belonging to
MEROPS (http://merops.sanger.ac.uk; Rawlings et al., 2012)
family U32 (GT-U32-CTD), which was obtained by sponta-
neous proteolytic fragmentation of the recombinant full-
length protein. Native GT-U32-CTD crystallized in space
group P212121 using 100 mM sodium acetate, 200 mM
ammonium acetate, 30%(w/v) polyethylene glycol 4000 pH 4.6
as the reservoir solution and the crystals diffracted to 1.10 A˚
resolution (see x2 and Table 1). The structure was determined
by single-wavelength anomalous diffraction of a seleno-
methione-derivatized variant of the protein, which crystallized
in space group P3221 using 100 mM sodium citrate, 2M
ammonium acetate pH 5.5 as the reservoir solution; the
crystals diffracted to 1.15 A˚ resolution. The resulting mole-
cular model was employed to solve the structure of the
orthorhombic crystal form, which revealed all of the residues
of the only chain present in the asymmetric unit plus one
(hypothetical) sodium cation, an acetate ion and 108 solvent
molecules. Table 1 provides a summary of the crystallographic
data-collection and ﬁnal model-reﬁnement parameters.
3.2. Architecture of GT-U32-CTD
The structure shows a compact distorted open -barrel
made up of eight -strands (1–8), into which the ﬁrst eight
residues (Ser334–Phe341) and the last single residue (Asn422)
are inserted (Fig. 1a). The ﬁrst six residues
are present with a reﬁned occupancy of
60%, which is in accordance with mass-
spectrometric analysis of carefully washed
crystals (see x2). The barrel is actually
arranged as a strongly twisted, curled and
arched antiparallel -sheet (6–5–7–2–
1–8–3–4; connectivity 1, +3, +1, 6,
1, +2, +3); the ﬂanking strands, 4 and 6,
do not interact with each other through their
main chains. In addition, 4 and 7 are close
to giving rise to a perfect barrel with 1–3
and 8 (Fig. 1a), but they do not contact
each other through their main chains either.
Instead, the gap is closed by the side chains
of Phe379, Gln381, Lys409 and Arg410
(Fig. 1b). The sheet wraps around a central
hydrophobic core formed by the side chains
of residues Ala342, Val345, Tyr348, Ala355,
Val357, Ala359, Phe363, Val369, Phe371,
Ile376, Phe379, Ile383, Gln381, Ala397,
Val404, Phe406, Val408, Leu412, Asn416
and Met418. In contrast, the surface is
mainly hydrophilic and shows seven lysines,
ﬁve arginines, ﬁve aspartates and ten gluta-
mates, which contribute to four salt bridges
(Asp367–Arg364, Glu370–Arg419, Glu377–
Arg410 and Asp395–Arg398; Fig. 1c).
Furthermore, a potential sodium cation was
tentatively assigned on the surface based on
very short binding distances to ﬁve liganding
O atoms (Asn378 O1, 2.35 A˚; Gly373 O,
2.38 A˚; Ile376 O, 2.28 A˚; a solvent molecule,
2.32 A˚; a symmetry-related Asp395 O2
atom, 2.38 A˚) arranged in a trigonal bipyr-
amidal coordination sphere. Finally, an
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Figure 1
(a) Ribbon-type plot of GT-U32-CTD with the eight -strands labelled and marked with their
ﬂanking residues. Residues participating in ion binding are also shown and labelled. Inset
(lower right): topology scheme of the protein. (b) Cartoon showing the side chains
participating in the central hydrophobic core. (c) As (b) but showing the charged residues
of the protein engaged in salt bridges. (d) C-type plot in stereo showing the superposed
structures of GT-U32-CTD (yellow), LepA (green), eRF3 (lilac), EF-1a (cyan) and EF-Tu
(red).
acetate ion was likewise found bound to the protein surface
anchored to His362 N"2 (2.90 A˚), Arg398 N2 (2.85 A˚) and a
solvent molecule (2.64 A˚) through one of its carboxylate O
atoms. The other O atom is bound by Arg398 N" (2.89 A˚), a
solvent molecule (2.74 A˚) and a symmetry-related Gln358 N"2
atom (3.20 A˚).
3.3. Structural relatives
Structure-similarity searches with GT-U32-CTD identiﬁed
the LepA protein (PDB entry 3cb4; Evans et al., 2008), release
factor eRF3 (PDB entry 3e20; Cheng et al., 2009), elongation
factor 1a (EF-1a: PDB entry 1skq; Vitagliano et al., 2004) and
elongation factor Tu (EF-Tu; PDB entry 2c77; Parmeggiani et
al., 2006) as the most similar structures, with Z-scores of 10.9–
11.0, r.m.s.d. values of 1.7–2.0 A˚ and aligned stretches of 78–80
residues. Superposition of these structures onto GT-U32-CTD
(Fig. 1d) revealed equivalent architectures, topologies and
connectivities despite negligible sequence identity (8–19%).
These structural relatives are all found in proteins that further
comprise an additional N-terminal guanine-nucleotide binding
domain and they participate in ribosomal protein translation
elongation or termination (Andersen et al., 2003). For the
elongation factors, it has been shown that the GT-U32-CTD-
like domains interact with aminoacyl-loaded tRNAs and
with antibiotics that target the protein-synthesis machinery
(Andersen et al., 2003; Parmeggiani et al., 2006). Accordingly,
a similar function to a protein engaged in binding is concei-
vable for the C-terminal domain of the putative U32-type
peptidase of G. thermoleovorans.
3.4. Crystal-packing analysis
Notwithstanding the interest of the abovementioned results,
the most striking feature of the present study is that the native
protein crystallized in an orthorhombic crystal form with an
extremely low solvent content of 24.5% (Matthews parameter
VM of 1.63 A˚
3 Da1; Matthews, 1968), which may at least
partially account for its strong diffraction power; crystals with
less solvent tend to diffract better (Kantardjieff & Rupp,
2003). In contrast, the selenomethionine-derivatized protein,
which only differs from the former by the replacement of two
S atoms by selenium within the 10 kDa molecule, crystallized
in a trigonal (i.e. higher symmetry) space group with 30.0%
solvent content (VM = 1.75 A˚
3 Da1). In addition, none of the
abovementioned structural relatives packed with less than
39% solvent. Detailed inspection of the native crystal lattice
(Fig. 2) conﬁrmed very tight binding of the protein molecules
within the crystal, with almost no solvent channels and only
ordered solvent molecules ‘gluing’ the protein molecules
together. Each protein molecule interacts directly with its
surrounding crystallographic neighbours through a total of 136
close contacts and a total contact surface of 3480 A˚2, which
is in good agreement with the value obtained by adding the
binary interaction surfaces with each neighbour when calcu-
lated by another approach (3590 A˚2; see x2). The total contact
surface represents 65% of the total surface of a monomer,
which is far larger than generally reported for crystal contact
surfaces (15–49%; Carugo & Argos, 1997). In comparison,
tight protein–protein complexes, which exist not only in the
crystalline state but also in solution, such as proteinase–
inhibitor and antibody–antigen complexes, interact through
surfaces of 600–1000 A˚2, which correspond to 5–20% of their
total surfaces (Janin & Chothia, 1990). The shape comple-
mentarity between the surface of one GT-U32-CTD protomer
and its surrounding crystal relatives is 0.69. This falls within
the ranges of values for proteinase–inhibitor complexes (0.70–
0.76) and antibody–antigen complexes (0.64–0.68) (Lawrence
& Colman, 1993), which is noteworthy taking into account the
overall size of the total contact surface. Taken together, all of
these features explain the very tightly packed crystal lattice.
3.5. Low-solvent crystal structures in the PDB
To assess the uniqueness of the present packing in the
general context of the PDB, we investigated the cluster of
tightly packed protein crystal structures that have been
deposited. Detailed studies of the solvent-content distribution
have been published based on 116 (Matthews, 1968), 15 641
(Kantardjieff & Rupp, 2003) and 9081
(Chruszcz et al., 2008) macromolecular
crystal structures. These studies concluded
that 0.5% of nonredundant protein struc-
tures contain 25% solvent or less
(Kantardjieff & Rupp, 2003), which is
consistent with recent estimates that less
than 1% of proteins pack with less than 25–
26% solvent (C. Weichenberger & B. Rupp,
personal communication). As the annota-
tion of PDB entries with respect to solvent
content is inaccurate (Andersson &
Hovmo¨ller, 2000), we decided to perform a
comprehensive search for low-solvent-
content crystal structures (see x2). We
calculated the solvent contents from the
molecular masses of the annotated protein
sequences of 35 656 nonredundant protein
research papers
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Figure 2
Cartoon in stereo depicting the packing of one GT-U32-CTD molecule (shown with its
Connolly surface in yellow) surrounded by its crystallographic symmetry equivalents (shown as
white ropes).
crystal forms from the PDB determined using X-ray
crystallography (Berman et al., 2000), excluding virus capsids,
protein–DNA and protein–RNA complexes, synthetic
constructs and peptides (deﬁned as comprising 20 residues or
less). Artiﬁcially reduced values such as those obtained by
crystal desiccation or treatment with organic solvents were
also omitted. These calculations revealed only ten nonre-
dundant structures (0.028%) with a solvent content equal to
or less than 26% (see Table 2). These are human CD59 (79
residues; PDB entry 2uwr; Leath et al., 2007), human matrix
metalloproteinase 8 (163 residues; PDB entry 1zp5;
Campestre et al., 2006), the SH3 domain of chicken -spectrin
(62 residues; PDB entry 2f2v; Casares et al., 2007), two
structures of cypoviral polyhedrines from Wiseana signata
NPV (243 residues; PDB entry 3jvb; Coulibaly et al., 2007,
2009) and Bombyx mori (248 residues; PDB entry 2oh7;
Coulibaly et al., 2007), a ﬁve-stranded phenylalanine zipper
(56 residues; PDB entry 2guv; Liu et al., 2006), the CLP-
protease adaptor protein (176 residues; PDB entry 3gw1;
Roma´n-Herna´ndez et al., 2009), a small antifungal protein
from Ecommia ulmoides (41 residues; PDB entry 1p9g; Xiang
et al., 2004) and the mating pheromone Er-1 from Euplotes
raikovi (40 residues; PDB entry 2erl; Anderson et al., 1996),
with ﬁve and three disulﬁde bridges, respectively, and effector
protein AVR3A11 from Phytophthora capsici (65 residues;
PDB entry 3zr8; Boutemy et al., 2011). Interestingly, four of
the ten abovementioned structures crystallized in space group
P212121, which is also the presently reported space group (see
Table 1), and the other three in P21. This correlates well with
the observation by Chruszcz and coworkers that these two
space groups, together with P1, show the lowest mean solvent
content in general (see Table 3 in Chruszcz et al., 2008).
4. Conclusion
Accordingly, the present orthorhombic crystal form of GT-
U32-CTD represents one of the most tightly packed protein
structures reported to date; it shows a solvent content that is
more similar to those attributable to crystals of small organic
compounds than to a 10 kDa protein.
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